Summary
- Current Price
- As of today, TNGX price is $25.60, down -0.19% on
- Current Price All-Time High
- TNGX price is currently -25.56% below its historical high of $34.39 set on
- Market Cap
- TNGX current market cap is $4B, up +462.60% over the past 365 days
- Revenue
- TNGX current annual revenue is $62.38M, up +48.29% year-over-year
- Next Earnings
- As of today, the next earnings release for TNGX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Tango Therapeutics, Inc. |
| Ticker | NASDAQ: TNGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tangotx.com |
| Employees | 155 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $25.60 | |
| Price, 1D Change | -0.19% | |
| $4B | ||
| - | ||
| - | ||
| 1.36 | ||
| $62.38M | ||
| Revenue, 1Y Change | +48.29% | |
| -$0.87 | ||
| EPS, 1Y Change | +26.69% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | BCTG | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.87 | ||
| EPS Estimate | -$1.38 | N/A |
| EPS Est. Change | -58.20% | N/A |
| $62.38M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $25.60 | |
| Price Target | $40.00 | - |
| Price Tgt. Change | +56.25% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.21 | -$1.19 | +1.03% | |
| -$0.90 | -$0.87 | +2.58% | |
| -$1.38 | N/A | -58.20% | |
| -$1.64 | N/A | -87.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $45.99M | $42.07M | -8.53% | |
| $62.89M | $62.38M | -0.81% | |
| - | N/A | - | |
| $2.86M | N/A | -95.42% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $25.60 | |
| $18.30 | ||
| $28.52 | ||
| $20.08 | ||
| $27.16 | ||
| -$0.54 | ||
| 1.36 | ||
| $1.75 | ||
| 41.78 | ||
| 69.17% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $62.38M | ||
| -$0.87 | ||
| $60.10M | ||
| 96.34% | ||
| -$111.29M | ||
| -178.39% | ||
| -$101.59M | ||
| -162.85% | ||
| -$109.01M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.10 | ||
| 16.32 | ||
| 16.32 | ||
| - | ||
| - | ||
| 38.74 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 75.74 | ||
| 11.03 | ||
| -34.39 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $346.18M | ||
| $343.57M | ||
| $410.01M | ||
| $353.76M | ||
| $63.83M | ||
| $21.68M | ||
| $33.57M | ||
| $2.74M | ||
| $1.18M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $163.98M | ||
| $171.39M | ||
| $2.28M | ||
| $0.00 | ||
| $2.28M | ||
| $0.00 | ||
| $4,000.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$138.89M | ||
| -$40.87M | ||
| $222.50M | ||
| $1.05M | ||
| -$139.93M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Guggenheim | → | |
| Mizuho | → | |
| JP Morgan | ||
| Canaccord Genuity | → | |
| Jefferies | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Leerink Partners | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
No data
Screeners with TNGX
FAQ
- What is the ticker symbol for Tango Therapeutics, Inc.?
- The ticker symbol for Tango Therapeutics, Inc. is NASDAQ:TNGX
- Does Tango Therapeutics, Inc. pay dividends?
- No, Tango Therapeutics, Inc. does not pay dividends
- What sector is Tango Therapeutics, Inc. in?
- Tango Therapeutics, Inc. is in the Healthcare sector
- What industry is Tango Therapeutics, Inc. in?
- Tango Therapeutics, Inc. is in the Biotechnology industry
- What country is Tango Therapeutics, Inc. based in?
- Tango Therapeutics, Inc. is headquartered in United States
- When did Tango Therapeutics, Inc. go public?
- Tango Therapeutics, Inc. initial public offering (IPO) was on September 3, 2020
- Is Tango Therapeutics, Inc. in the S&P 500?
- No, Tango Therapeutics, Inc. is not included in the S&P 500 index
- Is Tango Therapeutics, Inc. in the NASDAQ 100?
- No, Tango Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Tango Therapeutics, Inc. in the Dow Jones?
- No, Tango Therapeutics, Inc. is not included in the Dow Jones index
- When was Tango Therapeutics, Inc. last earnings report?
- Tango Therapeutics, Inc.'s most recent earnings report was on August 10, 2026
- When does Tango Therapeutics, Inc. report earnings?
- The date for Tango Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- TNGX Official Website www.tangotx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1819133/000119312526092518/0001193125-26-092518-index.htm
- TNGX Profile on Yahoo Finance finance.yahoo.com/quote/TNGX
- TNGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tngx